Cite
HARVARD Citation
Belluomini, L. et al. (2022). Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas. Expert review of anticancer therapy. 22 (8), pp. 785-794. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Belluomini, L. et al. (2022). Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas. Expert review of anticancer therapy. 22 (8), pp. 785-794. [Online].